Ciprofloxacin in Respiratory Tract Infections

Authors

  • Faroque Ahmad Khan Department of Medicine Nassau County Medical Center East Meadow, New York USA

DOI:

https://doi.org/10.5915/23-1-14377

Keywords:

Quinolone, Ciprofloxacin, Respiratory Tract Infection

Abstract

DOI: http://dx.doi.org/10.5915/23-1-14377

Of the quinolone class of antimicrobials, only oral ciprofloxacin is currently approved for respiratory indications. Ciprofloxacin has good tissue penetration and is active against most gram-negative and gram-positive pathogens, including Staplylococcus sp. It is, however, less effective against anaerobic bacteria and Streptococcus pneumoniae. The drug may be useful for managing bacterial exacerbations of COPD and for treating elderly patients with respiratory tract infections, including nosocomial pneumonias. Ciprofloxacin probably alters metabolism of theophylline and some antacids interfere with its absorption and antibacterial activity.

Author Biography

Faroque Ahmad Khan, Department of Medicine Nassau County Medical Center East Meadow, New York USA

Department of Medicine
Nassau County Medical Center
East Meadow, New York
USA

M.B.

Downloads

Published

1991-01-01

Issue

Section

Review Articles